Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-23.28	113.92	148.49
Graham Fair Price	33.93	23.02	17.19
PEG	-58.48	0.69	1.66
Price/Book	2.93	7.64	7.43
Price/Cash Flow	-20.15	91.05	114.03
Prices/Earnings	-37.39	49.14	78.49
Price/Sales	-1.52	37.30	37.88
Price/FCF	-20.15	91.05	114.03
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.02	0.80	0.80
Operating Margin	38.22	0.30	0.22
ROA	74.22	0.02	0.01
ROE	0.02	0.04	64.40
ROIC	0.02	0.03	62.21
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.11	0.30	-64.15
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.02	0.51	2476.69
EPS QOQ	0.47	0.71	50.79
FCF QOQ	3.23	0.35	-89.11
Revenue QOQ	< 0.005	0.10	1361.12
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	100.75	-148.17	47.07
Days Sales Outstanding (DSO)	110.90	107.11	-3.42
Inventory Turnover	0.89	-0.61	-32.00
Debt/Capitalization	0.47	0.41	-12.47
Quick Ratio	0.99	0.64	-35.70
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	23.56	24.61	4.46
Cash	2.22	2.08	-6.41
Capex	-0.04	-0.03	20.56
Free Cash Flow	1.53	2.07	34.66
Revenue	4.62	5.04	9.18
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.19	0.76	-36.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.09	9.05	-35.82
Naive Interpretation	Member

06 - Financial Health · Bad

Rating